Birth weight and overweight or obesity risk in children under 3 years in China

Nan Li1, Enquing Liu, Shurong Sun

  • 1Tianjin Women's and Children's Health Center, Tianjin, China; Chronic Disease Epidemiology Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana.

Insights

Higher birth weight in children is linked to an increased risk of childhood overweight and obesity up to age three. This study highlights birth weight as a key factor in early-life weight management for children.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Childhood obesity is a growing global health concern.
  • Early life factors, including birth weight, are critical determinants of long-term health outcomes.
  • Understanding the relationship between birth weight and subsequent overweight/obesity is essential for preventative strategies.

Purpose of the Study:

  • To examine the association between various birth weight categories and the risk of developing overweight or obesity in children up to three years of age.
  • To quantify the increased odds of overweight/obesity associated with higher birth weights.

Main Methods:

  • A retrospective cohort study analyzing health care records of 55,925 children from birth to three years.
  • Body weight and length measurements were collected between 2009 and 2011.
  • Statistical analysis adjusted for multiple confounding factors including gestational age, maternal characteristics, socioeconomic status, and feeding methods.

Main Results:

  • The prevalence of overweight/obesity varied across age groups, with the highest rates observed at 0.5 and 1 year.
  • A significant positive association was found between higher birth weight and the risk of overweight/obesity from six months to three years.
  • Children with birth weights of 3,000-3,499g, 3,500-3,999g, 4,000-4,499g, and >4,500g had significantly increased odds ratios (1.35-4.90 folds) for overweight/obesity compared to the 2,500-2,999g reference group.

Conclusions:

  • Higher birth weight is a significant predictor of increased risk for overweight and obesity in early childhood.
  • These findings underscore the importance of monitoring birth weight as a potential indicator for future weight management interventions in children.
  • The study emphasizes the need for targeted public health initiatives addressing the link between birth weight and childhood obesity in the studied population.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
14.8K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554